Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(3):164-165; doi:10.1093/jnci/94.3.164
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Baldwin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldwin, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 3, 164-165, February 6, 2002
© 2002 Oxford University Press

NEWS

New Treatments Target Metastatic Tumors in Liver

Joyce Baldwin

The treatment of colorectal cancer and other cancers that have metastasized to the liver presents a set of unique issues. Surgical resection of the tumor is the established gold standard against which newer therapies are compared, but only a small percentage of patients are candidates for surgery, and there are clear risks associated with resection.

New techniques and chemotherapy agents are in clinical trials specifically for the 70% to 90% of patients with metastatic colon cancer who are not candidates for surgery.

About half of patients with colorectal cancer either have liver metastases at the time of diagnosis . . . [Full Text of this Article]

Radiofrequency Ablation

Brachytherapy

Hepatic Arterial Infusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?